Form 4 for EXEL EXELIXIS, INC.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0000939767-21-000100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-17 | 2021-11-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | S - Sale+OE | $18.09 | -47.5K | 411.2K | -10% | -$859.3K |
| DM | 2021-11-17 | 2021-11-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | F - Tax | $18.10 | -62.2K | 404.4K | -13% | -$1.13M |
| D | 2021-11-17 | 2021-11-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | M - OptEx | $6.21 | +47.5K | 458.7K | +12% | +$295.0K |
| D | 2021-11-17 | 2021-11-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | M - OptEx | $0.00 | -47.5K | 47.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | S | D | 47,500 | $18.09 | 411,240 | D | — | — | (F3) Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.94 to $18.28. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. |
| 2 | Common | Common Stock | 2021-11-15 | F | D | 2,323 | $18.10 | 402,099 | D | — | — | (F5) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 2, 2020. |
| 3 | Common | Common Stock | 2021-11-15 | F | D | 53,022 | $18.10 | 349,077 | D | — | — | (F6) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on October 22, 2020. |
| 4 | Common | Common Stock | 2021-11-15 | M | A | 47,500 | $6.21 | 458,740 | D | — | — | (F1) Includes 104,202 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
| 5 | Common | Common Stock | 2021-11-15 | F | D | 6,818 | $18.10 | 404,422 | D | — | — | (F4) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017. |
| 6 | Derivative | Option (right to buy) | 2021-11-15 | M | D | 47,500 | $0.00 | 47,500 | D | $6.21 · 2016-09-16 to 2022-09-15 | 47,500 Common Stock | (F8) The option, representing the right to purchase a total of 190,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. |